Cargando…

Pilot, Randomized, Blinded, Placebo-Controlled Trial Investigating the Correlation Between Acid Control and Heartburn Relief with 14 Days of Esomeprazole Treatment

INTRODUCTION: Reflux symptoms are frequently associated with esophageal acid exposure. However, other potential causes unrelated to acid secretion are possible, and the relationship between acid control and symptomatic improvement remains unclear. This study investigated the correlation between indi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miner, Philip B., Johnson, David A., Katz, Philip O., Li, Jing, Gatoulis, Sergio C., Pollack, Charles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6224004/ https://www.ncbi.nlm.nih.gov/pubmed/30255418 http://dx.doi.org/10.1007/s12325-018-0792-z

Ejemplares similares

Sustained efficacy following resolution of frequent heartburn with an over-the-counter regimen of esomeprazole 20 mg or placebo for 14 days: two randomized trials
por: Peura, David A., et al.
Publicado: (2018)

Analysis of the symptom response to esomeprazole 20 mg over days 1–4 of a 14-day course of treatment for frequent heartburn: results of two randomised controlled trials
por: Peura, David, et al.
Publicado: (2019)

Analysis of Clinical Predictors of Resolution of Sleep Disturbance Related to Frequent Nighttime Heartburn and Acid Regurgitation Symptoms in Individuals Taking Esomeprazole 20 mg or Placebo
por: Johnson, David A., et al.
Publicado: (2016)

Effects of Tegoprazan Versus Esomeprazole on Nighttime Heartburn and Sleep Quality in Gastroesophageal Reflux Disease: A Multicenter Double-blind Randomized Controlled Trial
por: Kim, Joon Sung, et al.
Publicado: (2023)

Heartburn relief with bicarbonate-rich mineral water: results of the randomised, placebo-controlled phase-III trial STOMACH STILL
por: Labenz, Joachim, et al.
Publicado: (2023)

Relationship between esomeprazole dose and timing to heartburn resolution in selected patients with gastroesophageal reflux disease
por: Orlando, Roy C, et al.
Publicado: (2010)

Anti-Heartburn Effects of Sugar Cane Flour: A Double-Blind, Randomized, Placebo-Controlled Study
por: Beckett, Jeffrey M., et al.
Publicado: (2020)

Dexlansoprazole for Heartburn Relief in Adolescents with Symptomatic, Nonerosive Gastro-esophageal Reflux Disease
por: Gold, Benjamin D., et al.
Publicado: (2017)

Fermented soy supplementation improves indicators of quality of life: a randomized, placebo-controlled, double-blind trial in adults experiencing heartburn
por: Fatani, Asmaa, et al.
Publicado: (2020)

Safety aspects and rational use of a naproxen + esomeprazole combination in the treatment of rheumatoid disease
por: Roberts, David N, et al.
Publicado: (2011)

Poliprotect vs Omeprazole in the Relief of Heartburn, Epigastric Pain, and Burning in Patients Without Erosive Esophagitis and Gastroduodenal Lesions: A Randomized, Controlled Trial
por: Corazziari, Enrico Stefano, et al.
Publicado: (2023)

Effect of esomeprazole versus placebo on pulmonary exacerbations in cystic fibrosis
por: DiMango, Emily, et al.
Publicado: (2014)

Double blind, randomised, placebo-controlled trial to evaluate the efficacy of esomeprazole to treat early onset pre-eclampsia (PIE Trial): a study protocol
por: Cluver, Catherine A, et al.
Publicado: (2015)

Short-Term Symptomatic Relief in Gastroesophageal Reflux Disease: A Comparative Study of Esomeprazole and Vonoprazan
por: Sakurai, Kouichi, et al.
Publicado: (2018)

Esomeprazole enhances the effect of ionizing radiation to improve tumor control
por: Hebert, Kassidy A., et al.
Publicado: (2021)

Microcurrent technology for rapid relief of sinus pain: a randomized, placebo‐controlled, double‐blinded clinical trial
por: Maul, Ximena A., et al.
Publicado: (2019)

Liq. Magnesiæ—A Remedy for Cardialgia (Heartburn.)
Publicado: (1872)

Efficacy of alginate-based reflux suppressant and magnesium-aluminium antacid gel for treatment of heartburn in pregnancy: a randomized double-blind controlled trial
por: Meteerattanapipat, Pontip, et al.
Publicado: (2017)

Melatonin in Assisted Reproductive Technology: A Pilot Double-Blind Randomized Placebo-Controlled Clinical Trial
por: Fernando, Shavi, et al.
Publicado: (2018)

Preparation and Characterization of Controlled-Release Floating Bilayer Tablets of Esomeprazole and Clarithromycin
por: Israr, Muhammad, et al.
Publicado: (2022)

A hidden history of heartburn: The milk-alkali syndrome
por: Swaminathan, Krishnan
Publicado: (2011)

Heartburn in Staff of Golestan Medical University, Northeast of Iran
por: Besharat, Sima, et al.
Publicado: (2009)

Prevalence of non-obstructive dysphagia in patients with heartburn and regurgitation
por: Batista, Andrea Oliveira, et al.
Publicado: (2020)

Carcinogenic NMDA Contamination of Drugs for Heartburn, Hypertension and Diabetes
por: Ali, Meher Binte
Publicado: (2021)

Clinical Characteristics of Esophageal Motility Disorders in Patients With Heartburn
por: Takahashi, Satsuki, et al.
Publicado: (2021)

TMAC Savings of 90% for Heartburn Drugs in the United States
por: Curtiss, Frederic R.
Publicado: (2006)

Intraperitoneal Levobupivacaine with or without Clonidine for Pain Relief after Laparoscopic Cholecystectomy: A Randomized, Double-blind, Placebo-controlled Trial
por: Govil, Nishith, et al.
Publicado: (2017)

Randomized Controlled Trial Comparing the Efficacy of Sustained-Release Formula of Mosapride-Plus-Esomeprazole Combination Therapy to Esomeprazole Monotherapy in Patients with Gastroesophageal Reflux Disease
por: Jeon, Hye Kyung, et al.
Publicado: (2022)

Efficacy of long-term milnacipran treatment in patients meeting different thresholds of clinically relevant pain relief: subgroup analysis of a randomized, double-blind, placebo-controlled withdrawal study
por: Mease, Philip J, et al.
Publicado: (2014)

Effect of esomeprazole on the pharmacokinetics of carbamazepine
por: Medhi, Bikash, et al.
Publicado: (2011)

Lansoprazole plus levosulpiride versus esomeprazole in participants with gastroesophageal reflux disease and erosive esophagitis: a double blinded randomized control trial
por: Umer, Muhammad Rizwan, et al.
Publicado: (2023)

Responsiveness of measures of heartburn improvement in non-erosive reflux disease
por: Junghard, Ola, et al.
Publicado: (2007)

Exploratory Study of Tegaserod for Dyspepsia in Women Receiving PPIs for Heartburn
por: Vakil, Nimish, et al.
Publicado: (2008)

Eosinophilic esophagitis prevalence in adults with dysphagia or heartburn: preliminary results
por: Boechat, Jose Laerte, et al.
Publicado: (2015)

Esophageal Epithelial-Derived IL-33 Is Upregulated in Patients with Heartburn
por: Sei, Hiroo, et al.
Publicado: (2016)

Juice Test for Identification of Nonerosive Reflux Disease in Heartburn Patients
por: Fernandes, Michel R, et al.
Publicado: (2018)

Is There a Way to Differentiate Esophageal Motility Disorders in Patients With Heartburn?
por: Kim, Sung Eun
Publicado: (2021)

Review of recent evidence on the management of heartburn in pregnant and breastfeeding women
por: Ali, Raja Affendi Raja, et al.
Publicado: (2022)

OTC Omeprazole for Your Heartburn - Enormous Value-for-Money Opportunity
por: Curtiss, Frederic R.
Publicado: (2004)

A Double-blind, Randomized, Multicenter Clinical Trial Investigating the Efficacy and Safety of Esomeprazole Single Therapy Versus Mosapride and Esomeprazole Combined Therapy in Patients with Esophageal Reflux Disease
por: Lee, Ju Yup, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_67gftqqb4jon5ei2o4voh7sikl